JENNIFER AUGUST: Open Payments
NPI 1871628693 · MASHPEE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,528 in 52 payments from 19 companies in 2025. Trend: 2023 $420 · 2024 $1,006 · 2025 $1,528
Food & beverage: $1,508Long term medical supply or device loan: $20
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $319 |
| Amgen Inc. | 11 | $186 |
| Insulet Corporation | 1 | $150 |
| Novo Nordisk Inc | 2 | $141 |
| Xeris Pharmaceuticals, Inc. | 5 | $109 |
| BETA BIONICS, INC. | 1 | $86 |
| Lilly USA, LLC | 4 | $72 |
| Medtronic, Inc. | 3 | $65 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
| GlaxoSmithKline, LLC. | 3 | $60 |
Products named: FREESTYLE LIBRE 3, OMNIPOD, Ozempic, EVENITY, iLet Bionic Pancreas, RECORLEV, MOUNJARO, MINIMED 780G.
Industry payments across MA — which companies pay providers there.
